Long-term cultured pre-B cells are able to differentiate into immunoglobulin (Ig)M-positive B cells (IgM ϩ cells) when transplanted into severe combined immunodeficient (SCID) mice. Based on previous studies, here we report the development of a reconstitution assay in nonobese diabetic/SCID (NOD/SCID) mice using pre-B cells, which allows us to study the role of calpains (calcium-activated endopeptidases) during B cell development as well as in B cell clonal deletion. Using this model, we show that calpastatin (the natural inhibitor of calpains) inhibits B cell receptor-induced apoptosis in IgM ϩ cells derived from transplanted mice. We thus hypothesize an important function for calpain in sculpting the B cell repertoire.
Introduction
Several steps are essential for hematopoietic stem cell differentiation to mature B cells (1) . Progenitor B cells (pro-B cells, identified by acquisition of B-220, CD43, and c-kit) can rearrange D H to J H segments in the Ig heavy chain locus and are then termed pre-BI cells. Maturation of pre-BI cells occurs when V H and DJ H segments join; the H chain appears in cytoplasm and assembles with the products of the 5 and V pre-B genes. This mechanism leads to acquisition of the pre-B cell receptor (pre-BCR); * at this stage, B cells are called pre-BII cells and become c-kit-and CD43 negative. Later in B cell development, rearrangement begins again, now in the Ig light chain locus; B cells thus express a complete surface IgM molecule and are then denominated immature B cells (1) . As the mechanisms that mediate IgH and IgL gene recombination are error prone, a large proportion of B cell precursors fails to express functional IgH and IgL molecules. Those with nonproductive rearrangements die in situ by apoptosis at the pre-BI to pre-BII transition, as they do not receive a survival signal (2) .
Another consequence of random V(D)J recombination is the generation of B cells that recognize endogenous selfantigens (3) . To avoid autoimmune manifestations, an important mechanism allows the elimination of self-reactive B cells via apoptosis (clonal deletion [3] ). The apoptotic process is executed by a group of proteases including caspases (cysteinyl aspartate-specific proteinases) and calpains (calcium-activated proteases [4] ). Implication of both caspases and calpains during B cell clonal deletion have been demonstrated in immature B cells (5) (6) (7) ; nevertheless, the biochemical events leading to apoptosis by the BCR are not entirely clear.
B cell development is controlled by IL-7, as indicated by analysis of IL-7 knockout mice (8) . Pre-B cells can be cultured in the presence of IL-7 (9); when transplanted into SCID mice, these cells differentiate into IgM-positive B cells (IgM ϩ cells [10] ). Based on these studies, we developed a reconstitution assay by transplanting long-term cultured pre-B cells in nonobese diabetic/SCID (NOD/SCID) mice, which lack innate and adaptive immunity (11) . To track the transplanted pre-B cells in vivo, we transduced them by infection with a Moloney murine leukemia virus retroviral vector (pLZR-IRES/GFP). This vector contains
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Calpastatin Regulates BCR-induced Apoptosis the green fluorescence protein (GFP) under the control of an internal ribosome entry site (IRES), which allows in vivo study of the evolution of these cells. This model thus served to analyze the role of calpains during the B cell differentiation process as well as during B cell clonal deletion. Here we demonstrate that calpastatin (the natural inhibitor of calpains) did not interfere with B cell differentiation in the reconstitution model; however, IgM ϩ cells expressing calpastatin showed intrinsic resistance to BCR-induced apoptosis. We therefore conclude that calpain has an important function in B cell clonal deletion and in establishing the B cell repertoire.
Materials and Methods
Cell Culture and Animal Facility. WEHI-231 immature B cells were cultured in RPMI-1640 (BioWhittaker) supplemented with 10% FCS, 2 mM l -glutamine, 10 U/ml penicillin, 10 g/ml streptomycin, 10 mM HEPES, and 50 M 2-mercaptoethanol (Sigma-Aldrich) and maintained at 37 Њ C in a humidified atmosphere with 5% CO 2 . Pre-BI cells were derived from adult BALB/c mouse bone marrow (BM), and cultured in IMDM supplemented with 10 U/ml penicillin, 10 g/ml streptomycin, 1 mM sodium pyruvate, nonessential amino acids, 50 M 2-mercaptoethanol, 2 mM l -glutamine, 10% FCS, and 3% supernatant from a murine IL-7-producing cell line. IgM ϩ / mock, IgM ϩ /GFP, and IgM ϩ /calpastatin cells were derived from NOD/SCID mice 2 mo after transplantation and single cell suspensions were prepared from BM. BM cells were flushed from femurs and tibiae and cultured in IMDM supplemented with 10 U/ml penicillin, 2 mM/ml l -glutamine, 10% FCS, and 3% supernatant from a murine IL-7-producing cell line. After 2 d in culture, suspension-growing cells were separated from BM adherent cells. Suspension cells were transferred to new plates in the same medium. Under these conditions, differentiated IgM ϩ cells proliferate for several weeks in the presence of IL-7 (data not shown). Male and female NOD-Lt/Sz-scid / scid (NOD/ SCID) mice, bred in our animal facility, were used at 4 to 6 wk of age. All experiments were performed in compliance with norms of our animal facility committee.
Antibodies and Reagents. Goat anti-mouse IgM, chain specific (10 g/ml; Jackson ImmunoResearch Laboratories) was used to induce apoptosis. To confirm calpastatin expression, we used goat anti-calpastatin (R-19; Santa Cruz Biotechnology, Inc.). For staining analysis, the following biotin-conjugated antibodies were used: anti-B220 (clone RA3-6B2), anti-CD43 (S7), anti-CD19 (1D3), anti-CD3 ⑀ chain (145-2C11), anti-Ter-119 (TER-119) and anti-Mac-1 (M1/70), anti-CD21 (7G6), anti-CD23 (B3B4), and anti-CD25 (7D4) (all from BD PharMingen); affinity-purified goat anti-IgM ( chain-specific), and anti-IgD ( ␦ chain-specific; SBA-1) (both from Southern Biotechnology Associates, Inc.). Streptavidin-SpectralRed (SPRD) was from Southern Biotechnology Associates, Inc. Actinomycin D (Act-D) was purchased from Sigma-Aldrich.
Flow Cytometry Analysis for Marker Expression. Cells were washed in PBS containing 2% FCS and 0.1% NaN 3 (staining PBS), incubated with biotin-conjugated antibodies (20 min, on ice), then washed with staining PBS, incubated with streptavidin-SPRD, and analyzed on an EPICS XL flow cytometer (Beckman Coulter).
Assessment of Apoptotic Cell Death. Apoptosis was evaluated by staining cellular DNA with the DNA intercalator propidium iodide (PI) using a semiautomatic procedure (DNA-Prep Reagents; Beckman Coulter), followed by analysis on an EPICS XL flow cytometer. In brief, cells (10 5 -10 6 ) were recovered by centrifugation, resuspended in 100 l of PBS, then permeabilized and stained by addition of 100 l of detergent reagent followed by 1 ml of PI solution. After mixing, samples were incubated (37 Њ C, 30 min) and analyzed in flow cytometry. Apoptosis was determined as the percentage of DNA located in the hypoploid subG 0 /G 1 peak of the cell cycle.
Western Blot Analysis. Cells (10 6 ) were collected, washed with ice-cold PBS, and resuspended in RIPA lysis buffer (20 mM Tris-HCl, pH 8, 137 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 10% glycerol, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, and protease inhibitors). Lysate protein content was quantified using the DC protein assay (Bio-Rad Laboratories). After SDS-PAGE under reducing conditions, proteins were transferred to nitrocellulose membranes (Bio-Rad Laboratories), which were blocked overnight with 5% nonfat dry milk in TBS buffer (20 mM TrisHCl, pH 7.5, 150 mM NaCl). Subsequent antibody incubations and membrane washes were performed in TBS-T buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% Tween 20) containing 1% nonfat milk. After 2 h, antibody incubation and washing, PO-conjugated anti-goat was added for 1 h. Blots were washed extensively and developed using the enhanced chemoluminescence (ECL) system (Amersham Pharmacia Biotech).
Cloning of Calpastatin and Retroviral Transduction. We used a Moloney murine leukemia virus-based retroviral vector (pLZR-IRES/GFP), which was obtained from the pLZR-CMV-gfp plasmid (12) by replacing the enhanced GFP (EGFP) sequence with the IRES/gfp cassette from plasmid pIRES2/EGFP (CLONTECH Laboratories, Inc.). Murine calpastatin cDNA (13) was cloned into the EcoRI site of the pLZR-IRES/GFP vector to generate a pLZR-calpastatin/IRES/GFP construct. GFP ϩ cells were monitored and sorted in a Beckman Coulter EPICS Altra Hypersort. Retrovirus was produced by transient transfection of 293T cells (12, 14) . For viral transduction, 10 5 cells (WEHI-231 or pre-BI cells) were incubated 4 h with 5 g/ ml of protamine sulphate (Sigma-Aldrich) in 1 ml of retroviral supernatant or in virus-free medium. Infection was performed at 37 Њ C and repeated 24 h later under the same conditions. Calcium Determination. Changes in intracellular Ca 2 ϩ concentration were monitored using the fluorescent probe Indol-AM (Molecular Probes). Cells (10 7 /ml) were washed three times in HBB buffer (1 ϫ Hank's balanced salt solution, 0.1% BSA, and 10 mM Hepes, pH 7.5), then incubated with 3 M Indol-AM (30 min, 37 Њ C). After incubation, cells were washed and resuspended at 0.8 ϫ 10 6 cells/ml in HBB buffer, then maintained at 4 Њ C until anti-IgM addition. Calcium mobilization in response to 10 g/ ml of anti-IgM was determined at 37 Њ C by fluorimetry.
Results

Calpastatin Prevents BCR-induced Apoptosis in the WEHI-231
Immature B Cell Line. The immature B cell WEHI-231 has been used as a model for B cell tolerance based on its phenotype (sIgM high sIgD low ), which parallels that of immature B cells. Although many early signal transduction events through the BCR have now been elucidated, the biochemical events leading to apoptosis are not entirely clear. Molecular dissection of the mechanisms and biochemical pathways involved in these changes showed that calpain activation has an important role in the apoptotic ma-chinery (6, 7). The best-characterized calpains are the ubiquitously expressed calpain-1 and calpain-2 (also called catalytic subunits), which are activated by calcium (15) . Calpain activity can be regulated by a p30 regulatory subunit with chaperone-like effects on the refolding of the catalytic subunits (16, 17) , and by calpastatin, which inhibits calpain activation by interacting with both the active site and the calmodulin-like Ca 2 ϩ -binding domain of calpains (18) .
To study the role of calpains during BCR-induced apoptosis, we expressed calpastatin in WEHI-231 cells. We transduced them using the pLZR-IRES/GFP retroviral vector (see Materials and Methods), with GFP under the control of an IRES ( Fig. 1 A) ; this vector is based on others described previously. We cloned murine calpastatin cDNA in the pLZR-IRES/GFP vector to generate a construct (pLZR-calpastatin/IRES/GFP; Fig. 1 A) . WEHI-231 cells were then transduced by retroviral infection using both pLZR-IRES/GFP and pLZR-calpastatin/IRES/GFP to generate WEHI-231/GFP and WEHI-231/calpastatin cells (see Materials and Methods); cells were monitored and sorted (see Materials and Methods). After sorting, Western blot analysis for calpastatin expression was performed using total extracts from WEHI-231/GFP and WEHI-231/calpastatin cells, as well as from nontransduced WEHI-231 cells (WEHI-231/mock cells; Fig. 1 B) . Apoptosis analysis of these cells showed that calpastatin inhibited BCR-induced apoptosis (Fig. 1 C) , confirming the implication of calpains in anti-IgM-induced apoptosis. To clarify whether calpastatin has a general survival effect on WEHI-231 cells, we treated them with Act-D, which induces apoptosis via cytochrome c release from mitochondria. This apoptotic pathway is not found during anti-IgM-induced apoptosis in WEHI-231 cells (6) . Act-D-induced apoptosis is not blocked by calpastatin overexpression in these cells (Fig. 1  C) , indicating that calpastatin is not a general apoptotic inhibitor, but that its inhibitory effect is cell death stimulus specific. As the presence of autolytic calpain-2 fragments indicate calpain-2 activation (19, 20) , we performed Western blot analysis for calpain-2 ( Fig. 1 D) . We detect calpain-2 processing after anti-IgM-induced apoptosis in 
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Calpastatin Regulates BCR-induced Apoptosis WEHI-231 cells ( Fig. 1 D) ; nonetheless, calpastatin overexpression inhibits calpain-2 processing incompletely, or possibly the cell compensates for the inhibition by producing additional free calpain-2 (Fig. 1 D) . This result may explain why calpastatin does not block apoptosis completely in WEHI-231 cells.
Calpastatin Expression Does Not inhibit IL-7 Deprivationinduced Apoptosis in Long-Term Cultured
Pre-BI Cells. IL-7 controls the process of hematopoietic stem cell differentiation to mature B cells (1, 8) . BM-derived pre-B cells proliferate in vitro in the presence of IL-7, whereas its absence triggers apoptosis (9) . To analyze the role of calpastatin as an apoptosis inhibitor during IL-7 deprivation-induced apoptosis, we derived pre-BI cells from adult BALB/c mouse BM and cultured them in IL-7. Long-term cultured pre-BI cells were then transduced by retroviral infection using the pLZR-IRES/GFP and pLZR-calpastatin/IRES/GFP constructs to generate pre-BI/GFP and pre-BI/calpastatin cells. Cells were monitored and sorted (see Materials and Methods), after which pre-BI/GFP and pre-BI/calpastatin cells were cultured in vitro in the presence of IL-7; untransduced pre-BI cells (pre-BI/mock) were used as a control.
Staining analysis for the surface proteins B220, CD43, and IgM showed that GFP expression in long-term cultured pre-BI cells does not interfere with the pre-BI phenotype (Fig. 2 A) . We observed that long-term cultured GFP-positive cells gradually lost GFP protein expression after 2 wk in culture; this effect has been observed in other cell types in which long-term in vivo expression from the viral promoter is not completely satisfactory (21, 22) . In addition, pre-BI/calpastatin cells lose more GFP expression than do pre-BI/GFP cells. Several studies have been conducted to determine the parameters that influence recognition of the start codon in IRES-dependent translation initiation in bicistronic constructs. These studies show that the secondary structure of the region that separates the 3 Ј end of the IRES element from the initiator codon play an essential role in start codon recognition (23) . The insertion of sequences containing an additional start codon upstream of the IRES element greatly reduce the translation efficiency of the second gene, both in vivo and in vitro (24) . Moreover, it has been shown that expression of genes upstream of IRES elements interferes with GFP expression (25, 26) . Here we made a similar observation in pre-BI cells expressing calpastatin plus GFP; GFP expression is altered in these cells by upstream calpastatin expression.
Apoptosis analysis after IL-7 deprivation showed that calpastatin expression did not block IL-7 deprivationinduced apoptosis ( Fig. 2 B) ; Western blot analysis for calpastatin was performed as an expression control (Fig. 2 B) . These results, together with those from the WEHI-231 cells, demonstrate the contribution of calpains during BCR-induced apoptosis, but not during IL-7 deprivationinduced apoptosis in pre-BI cells.
Characterization of the Reconstitution Assay in NOD/SCID Mice Using Long-Term Cultured Pre-BI Cells.
In vitro-cultured pre-BI cells differentiate into IgM ϩ cells when transplanted into SCID mice (9, 10) . This process is regulated by expression of the recombinant protein recombination activating gene (RAG)-2 (27) . Using long-term cultured pre-BI/GFP cells, which allow in vivo cell tracking, we developed a reconstitution assay in NOD/SCID mice to confirm the ability of pre-BI cells to differentiate into IgM ϩ cells. Pre-BI/GFP cells (10 7 cells) were transplanted intravenously into 300 Gy-irradiated NOD/SCID mice. As described previously (10), the dominance of B cell lymphopoiesis in BM is detected between 2 and 4 mo after transplantation (data not shown). Transplanted pre-BI/ GFP cells differentiated into IgM ϩ B cells (IgM ϩ /GFP cells), which were identified by expression of B220 ϩ , CD19 ϩ , IgM ϩ , and the lack of IgD expression (data not shown). Staining controls for CD3 (for T cells), Mac-1 (macrophages), and Ter-119 (erythrocytes) were negative. In conclusion, these data confirm the ability of long-term cultured pre-BI cells to differentiate into IgM ϩ cells in BM, as well as the possibility to track these cells in vivo.
Pre-BI Cells Expressing Calpastatin Differentiate into IgM ϩ B Cells Showing Impaired Clonal Deletion In Vitro.
Expression of murine calpastatin prevents BCR-induced apoptosis in WEHI-231 cells, confirming calpain implication during anti-IgM-induced apoptosis in this model of B cell tolerance. We used the reconstitution assay described above to explore the role of calpain in BCR-triggered apoptotic machinery. This assay allowed us to study the impact of calpastatin expression as an inhibitor of BCR-induced apoptosis in IgM ϩ cells. Pre-BI/mock, pre-BI/GFP, and pre-BI/ calpastatin cells were thus transplanted into NOD/SCID mice to derive IgM ϩ /mock, IgM ϩ /GFP, and IgM ϩ /calpastatin cells (see Materials and Methods). To explore whether calpastatin expression has an influence on B cell differentiation, we sorted GFP ϩ cells from transplanted NOD/SCID mice. FACS ® analysis of cells from BM of transplanted pre-BI/GFP and pre-BI/calpastatin NOD/ SCID mice indicates that calpastatin does not alter B cell differentiation (Fig. 3) . In addition, the results indicate that B cells obtained from transplanted NOD/SCID mice are B220 ϩ , IgM ϩ , IgD Ϫ , CD19 ϩ , CD25 Ϫ , CD43 ϩ , CD21 Ϫ , and CD23 Ϫ . Similar results were found when human CD34 ϩ stem cells were transplanted into NOD/SCID mice, generating B cells characterized by expression of the surface markers IgM ϩ , IgD Ϫ , CD19 ϩ , CD43 Ϫ , CD21 Ϫ , CD23 Ϫ , and Mac-1 Ϫ (28). Novelli's group identified these as B-1 cells using the reciprocal CD23 and CD43 expression pattern, as B-1 cells are CD23 Ϫ CD43 ϩ , whereas B-2 cells are CD23 ϩ CD43 Ϫ (29, 30) .
IgM ϩ cells from reconstituted NOD/SCID mice expressed the BCR and calpastatin, even 2 to 3 wk after isolation from marrow (Fig. 4, A and B) . As sustained Ca 2ϩ in- flux is required for calpain activation (18), we tested whether BCR cross-linking triggered Ca 2ϩ influx in derived IgM ϩ /mock, IgM ϩ /GFP, and IgM ϩ /calpastatin cells (Fig. 4 A) . In addition, we analyzed several surface markers in IgM ϩ cells derived from transplanted NOD/SCID mice, and found no significant differences among IgM ϩ /mock, IgM ϩ /GFP, and IgM ϩ /calpastatin cell lines (Fig. 4 A) .
To validate the role of calpastatin as an inhibitor of BCR-induced apoptosis, we analyzed apoptosis at 24 and 48 h after anti-IgM cross-linking. IgM ϩ /calpastatin cells presented intrinsic resistance to BCR-induced apoptosis (Fig. 4 C) , confirming calpain implication in this type of apoptosis, indicating an important function for calpains in generating the B cell repertoire.
Discussion
Apoptosis is the most common physiological form of cell death; it occurs during embryonic development, tissue remodeling, immune regulation, cell activation, and tumor regression (31) . In the hematopoietic system, B cell generation is regulated by a negative selection mechanism, by which B cells undergo a BCR-activated apoptotic process. The apoptotic machinery is activated when the BCR recognizes endogenous self antigens or antigens in the absence of costimulating signals (3). The immature B cell WEHI-231 has been widely used as a model of B cell tolerance, based on its capacity to undergo apoptosis after BCR crosslinking, which induces calpain activation and subsequent apoptosis (6, 7) . Calpain activation triggers destruction of distinct proteins involved in cell cycle, cytoskeletal modeling, cell spreading, as well as multiple transcription factors, thus causing apoptosis (18) ; nonetheless, the contribution of calpains to BCR-induced apoptosis is unknown.
Calpain activation takes place after calcium mobilization, which is triggered by BCR cross-linking (18, 32) . Phospholipase C (PLC-␥) activation by BCR cross-linking leads to phospholipid hydrolysis, yielding inositol 1,4,5-tris phosphate (IP 3 ) and diacylglycerol (DAG). IP 3 then binds IP 3 receptors located in the endoplasmic reticulum, causing Ca 2ϩ release from internal stores (32) . Modulation of BCR activation can be mediated by inhibitory receptors such as F c ␥RII and paired immunoglobulin-like receptor B (PIR-B; reference 33), whose activation recruits the phosphatase Src homology 2 domain-containing 5Ј inositol phosphatase (SHIP), which mediates some inhibitory signaling such as PLC-␥ inhibition and subsequent BCR cross-linkinginduced Ca 2ϩ mobilization (33) . As a consequence of this inhibitory mechanism, F c ␥RII and PIR-B stimulation prevent BCR-induced apoptosis.
Calpains are implicated in other apoptotic models such as TGF-␤-induced apoptosis in B lymphocytes (34) , TCRinduced apoptosis in thymocytes (35) , or neuronal cell death (36) . In neurons, calpain activation induces cleavage of p35 (a neuron-specific activator of cyclin-dependent kinase 5, cdk5) giving rise to p25, which accumulates in the brain of patients with Alzheimer's disease. Conversion of p35 to p25 causes prolonged activation of cdk5, which hyperphosphorylates tau, disrupts the cytoskeleton, and promotes apoptosis (36) . In B cells, however, the calpaindriven apoptosis mechanism involves processing and subsequent activation of caspase-7, indicating the distinct induction mechanisms induced by calpain activation (6, 7).
Here we analyzed the role of the calpains in B cell clonal deletion by expressing their natural inhibitor, calpastatin, to study the contribution of these proteases to this process. We demonstrate that calpastatin expression inhibited BCR-induced apoptosis in WEHI-231 cells, as well as in IgM ϩ B cells from reconstituted NOD/SCID mice. The inhibition ability of calpastatin is specific for BCR-induced apoptosis, as calpastatin expression did not block IL-7 deprivation-induced apoptosis in pre-BI cells or Act-Dinduced apoptosis in WEHI-231 cells. These data indicate the selective ability of calpastatin as an apoptosis inhibitor, and its capacity to modulate the B cell repertoire by regulating clonal deletion.
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